embecta to Participate at the 2026 BofA Securities Global Health Care Conference
Embecta (Nasdaq: EMBC) will present at the 2026 BofA Securities Global Health Care Conference in Las Vegas on May 13, 2026 at 3:00 p.m. PT / 6:00 p.m. ET.
Rhea-AI Summary
Embecta (Nasdaq: EMBC) will present at the 2026 BofA Securities Global Health Care Conference in Las Vegas on May 13, 2026 at 3:00 p.m. PT / 6:00 p.m. ET. Audio webcasts will be available via the News & Events section of the company's investor relations site at investors.embecta.com.
Details
News Market Reaction – EMBC
On May 8, the day this news came out, EMBC closed 1.11% above the previous close.
Data tracked by StockTitan Argus for the May 8 session.
Key Figures
- Q2 2026 revenue
- $221.8 million
- Quarter ended March 31, 2026; down from $259.0 million
- Revenue decline
- 14.4%
- Q2 2026 year-over-year revenue change
- Q2 gross margin
- 57.6%
- Down from 63.4% in prior-year quarter
- Q2 net loss
- $4.1 million
- Quarter ended March 31, 2026; EPS $(0.07)
- Six-month revenue
- $483.0 million
- First six months of fiscal 2026
- Cash balance
- $193.4 million
- Cash, equivalents and restricted cash as of March 31, 2026
- Debt principal
- $1.342 billion
- Total principal debt outstanding as of March 31, 2026
- Share repurchase plan
- $100 million
- Three-year share repurchase authorization
Historical Context
-
Quarterly cash dividend declared following broader capital allocation changes.
-
Second quarter fiscal 2026 results and webcast details released.
-
Announcement of timing and access details for Q2 2026 results call.
-
Agreement to acquire Owen Mumford to expand drug-delivery platforms.
-
New chairman and lead independent director appointed after prior chair’s retirement.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the 2026 BofA Securities Global Health Care Conference in Las Vegas on Wednesday, May 13, 2026 at 3:00 p.m. PT / 6:00 p.m. ET.
Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.